| 【Company Research】InnoScience (2577 HK) - 1H26 takes a breather as mix and margins improved |
| 【Company Research】PICC P&C (2328 HK) - Interim DPS +41.7% YoY a +VE surprise; Market pivots to 2H26E catastrophe claims outlook |
| 【Company Research】BaTeLab (2149 HK) - Pricing power now and capacity growth next; Maintain BUY |
| 【Company Research】Iluvatar CoreX (9903 HK) - Trust the process; 2H26 ramp ahead |
| 【Company Research】Horizon Robotics (9660 HK) - Re-acceleration on HSD expansion, overseas |
| 【Company Research】Z.AI (2513 HK) - Capability converting into commercial scale |
| 【Company Research】DualityBio (9606 HK) - Eyes on the upcoming ADC + IO2.0 data readouts |
| 【Company Research】CR MixC Lifestyle (1209 HK) - Broadening drivers to ease residential PM reliance; Maintain BUY |
| 【Company Research】Zenergy (3677 HK) - 1H26 a mixed bag; margin recovery from 2H26 |
| 【Company Research】CPIC (2601 HK) - Key metrics stayed robust; first interim dividend declared representing 19.1% payout |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
